Myriad Genetics, SOPHiA GENETICS and AstraZeneca are collaborating to advance Myriad’s prostate cancer genomic instability ...

A genetic diagnosis can bring immense emotional relief by offering a concrete biological explanation and reassuring parents that it was not their fault.

A team of hearing specialists at Vanderbilt Health analyzed thousands of data samples in the institution's BioVU biobank to ...

The team, composed of investigators from clinical audiology, ear surgery and general otolaryngology, was led by co-first ...

New study suggests that settlement of the Pacific occurred in a migration process with what the authors call a series of ...

Universal germline genetic testing of nearly 40,000 patients with solid tumors detected a substantial proportion of inherited gene variants that would have been missed by the standard germline testing ...

She had just diagnosed our 11-year-old daughter, Maya, with Nicolaides-Baraitser syndrome, a genetic condition so rare there ...

New data from the 8,660-participant ROPAD cohort corroborate that ITSN1 loss-of-function variants raise Parkinson's disease ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine and SOPHiA GENETICS (NASDAQ: SOPH) today announce a collaboration to advance new prostate ...

Brings more than 25 years of experience in clinical strategy, biostatistics and regulatory submissions from Abivax, Alumis, MyoKardia and ...

A decades-old Arizona mystery has been solved. Remains found in 1982 have been identified as missing Buckeye teen Mitchell ...

SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support ...